Chronic Kidney Disease: ACT - 2021
To begin the course, please login or register by clicking ENROLL. After logging in, you will be able to complete the pretest and view the video/documents. You will have the option to complete the posttest, evaluation and receive credit. Some courses may have an associated cost.
Starts On:
9/29/2020: 12:00 AM
Ends On:
6/23/2021: 12:00 AM
Session Type:
Internet Activity Enduring Material
Credits:
1
Description:
Aman Kaur Chawla, MD is a Senior Clinical Writer for Lumeris
Thomas D. Doerr, MD is the Chairman, Clinical Strategy Committee, Board of Directors for Essence Group Holdings Corporation
Cheryl Earls, RN, BSN, PAHM is a Senior Clinical Consultant for Lumeris
Sara F. Hicks, MSN, FNP-BC is a Senior Clinical Consultant for Lumeris
Lesley Ann Watson, BS, RPH is a Clinical Informatics Analyst for Lumeris
Dani Willett, RN is a Clinical Consultant for Lumeris The committee members have nothing to disclose.
S. Troy McMullin, PharmD is the Director of Clinical Informatics for Lumeris
The committee member holds stock equity in Johnson & Johnson, TEVA.
Allyson R. Zazulia, MD is a Professor of Neurology and the Associate Dean for Continuing Medical Education, Washington University School of Medicine. Dr. Zazulia has no financial relationships to disclose.
Committee members should indicate if speaking off label. Staff of the CME department have oversight of on line modules. All members of the CME department have nothing to disclose.
Planning Committee
Eric W. Alexander, PharmD, BCPS is a Clinical Consultant for LumerisAman Kaur Chawla, MD is a Senior Clinical Writer for Lumeris
Thomas D. Doerr, MD is the Chairman, Clinical Strategy Committee, Board of Directors for Essence Group Holdings Corporation
Cheryl Earls, RN, BSN, PAHM is a Senior Clinical Consultant for Lumeris
Sara F. Hicks, MSN, FNP-BC is a Senior Clinical Consultant for Lumeris
Lesley Ann Watson, BS, RPH is a Clinical Informatics Analyst for Lumeris
Dani Willett, RN is a Clinical Consultant for Lumeris The committee members have nothing to disclose.
S. Troy McMullin, PharmD is the Director of Clinical Informatics for Lumeris
The committee member holds stock equity in Johnson & Johnson, TEVA.
Allyson R. Zazulia, MD is a Professor of Neurology and the Associate Dean for Continuing Medical Education, Washington University School of Medicine. Dr. Zazulia has no financial relationships to disclose.
Committee members should indicate if speaking off label. Staff of the CME department have oversight of on line modules. All members of the CME department have nothing to disclose.
Authors
Eric W. Alexander, PharmD, BCPS is a Clinical Consultant for Lumeris
Objectives:
The intended result of this activity is increased knowledge/competence, and upon completion of this course, participants should be able to:
- Describe screening for chronic kidney disease, including screening intervals for at-risk patients
- Identify key coding considerations for chronic kidney disease based on the staging of chronic kidney disease developed by the Kidney Disease Improving Global Outcomes (KDIGO) workgroup
- List key treatment considerations, including the importance of blood pressure, cholesterol, and glucose control
Additional Information:
Target Audience: This course is designed for Internists and Family Medicine physicians, pharmacists, nurse practitioners and physician assistants.
Publication Date: September 29, 2020
Expiration Date: June 30, 2021
Target Audience: This course is designed for Internists and Family Medicine physicians, pharmacists, nurse practitioners and physician assistants.
Publication Date: September 29, 2020
Expiration Date: June 30, 2021
Accreditation Information:
In support of improving patient care, this activity has been planned and implemented by Lumeris and Washington University School of Medicine in St. Louis. Washington University School of Medicine in St Louis is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit available for this activity:
In support of improving patient care, this activity has been planned and implemented by Lumeris and Washington University School of Medicine in St. Louis. Washington University School of Medicine in St Louis is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit available for this activity:
Credit Statement:
American Medical Association (AMA Credit)
Washington University School of Medicine in St. Louis designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC Credit)
Washington University School of Medicine in St. Louis designates this enduring material for a maximum of 1 ANCC contact hour.
American Academy of Family Physicians (AAFP Credit)
This enduring material activity, Lumeris Clinical Education Course, has been reviewed and is acceptable for up to 1 Prescribed credit by the American Academy of Family Physicians. AAFP certification begins June 21, 2020. Term of approval is for one year from this date. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
LUMERIS's mission is to lead the positive evolution of healthcare by providing doctors with the tools, information, and financial incentives they need to practice quality medicine, thereby providing our members access to high-quality service and affordable medical care. The LUMERIS clinical decision support team is made up of physicians, clinical pharmacists, nurse practitioners, and information technology experts. LUMERIS accepts no grants, advertising or donations from the pharmaceutical industry or medical device manufacturers.
American Medical Association (AMA Credit)
Washington University School of Medicine in St. Louis designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC Credit)
Washington University School of Medicine in St. Louis designates this enduring material for a maximum of 1 ANCC contact hour.
American Academy of Family Physicians (AAFP Credit)
This enduring material activity, Lumeris Clinical Education Course, has been reviewed and is acceptable for up to 1 Prescribed credit by the American Academy of Family Physicians. AAFP certification begins June 21, 2020. Term of approval is for one year from this date. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
LUMERIS's mission is to lead the positive evolution of healthcare by providing doctors with the tools, information, and financial incentives they need to practice quality medicine, thereby providing our members access to high-quality service and affordable medical care. The LUMERIS clinical decision support team is made up of physicians, clinical pharmacists, nurse practitioners, and information technology experts. LUMERIS accepts no grants, advertising or donations from the pharmaceutical industry or medical device manufacturers.
References:
- Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. Suppl. 2013;3:1-150.
- Chronic Kidney Disease in the United States, 2019. Centers for Disease Control and Prevention website. URL: https://www.cdc.gov/kidneydisease/pdf/2019_National-Chronic-Kidney-Disease-Fact-Sheet.pdf. Published: 2019. Accessed: September 1, 2020.
- American Diabetes Association. Standards of Medical Care in Diabetes—2020. Diabetes Care. 2020;43(Suppl. 1):S1- 212.
- Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71(6):e13-e115.
- Makani H, Bangalore S, Desouza KA , Shah A, Messerli FH. Efficacy and safety of dual blockade of the renin-angiotensin system: meta-analysis of randomized trials. BMJ. 2013;346:f360.
Disclosure Information:
It is the policy of Washington University School of Medicine in St. Louis, Continuing Medical Education, to ensure balance, independence, objectivity and scientific rigor in all its educational activities. All planners, faculty and other persons who may influence content of this CME activity have disclosed all relevant financial relationships with commercial interests. All disclosures have been reported and are indicated with their presentations. Any potential conflicts were addressed and resolved.
Presenters are also expected to openly disclose inclusion of discussion of any off-label, experimental, or investigational use of drugs or devices in their presentations.
Presentations are expected to be based on evidence that is accepted within the profession of medicine as adequate justification for their indication in the care of patients. All scientific research should conform to the generally accepted standards of experimental design, data collection and analysis. These presentations are not an endorsement of any commercial interests.
These presentations are the views and experiences of the presenters. The presenters' views do not represent the policy or position of Washington University School of Medicine in St. Louis. Washington University School of Medicine in St. Louis, Continuing Medical Education, is the provider for CME credits.
Presenters are also expected to openly disclose inclusion of discussion of any off-label, experimental, or investigational use of drugs or devices in their presentations.
Presentations are expected to be based on evidence that is accepted within the profession of medicine as adequate justification for their indication in the care of patients. All scientific research should conform to the generally accepted standards of experimental design, data collection and analysis. These presentations are not an endorsement of any commercial interests.
These presentations are the views and experiences of the presenters. The presenters' views do not represent the policy or position of Washington University School of Medicine in St. Louis. Washington University School of Medicine in St. Louis, Continuing Medical Education, is the provider for CME credits.
Category:
ADSP Clinical Education
